These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23807680)

  • 1. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD1L is a novel independent prognostic factor for gastric cancer.
    Su Z; Zhao J; Xian G; Geng W; Rong Z; Wu Y; Qin C
    Clin Transl Oncol; 2014 Aug; 16(8):702-7. PubMed ID: 24258459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.
    He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF
    BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
    He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
    Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma.
    Sun J; Zhang L; Zhao H; Qiu X; Chen W; Wang D; Ban N; Fan S; Shen C; Xia X; Ji B; Wang Y
    Cell Mol Neurobiol; 2016 May; 36(4):565-76. PubMed ID: 26162969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
    Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
    Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer.
    Zhao Q; Shen WH; Chen ZW; Zhou ZS; Ji HX
    Int J Clin Exp Pathol; 2012; 5(5):422-7. PubMed ID: 22808294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.
    Su FR; Ding JH; Bo L; Liu XG
    Exp Ther Med; 2014 Dec; 8(6):1745-1750. PubMed ID: 25371726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SPHK1 expression is associated with poor prognosis in bladder cancer.
    Meng XD; Zhou ZS; Qiu JH; Shen WH; Wu Q; Xiao J
    Tumour Biol; 2014 Mar; 35(3):2075-80. PubMed ID: 24092575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
    Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
    Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
    Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
    Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.
    Wu Z; Wang S; Xue P; Wang S; Wang G; Zhang W
    Medicine (Baltimore); 2017 May; 96(19):e6640. PubMed ID: 28489738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHD1L: a novel oncogene.
    Cheng W; Su Y; Xu F
    Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.